Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Price Reaction to Earnings Reports

View detailed tables showing price action before and after earnings announcements, ranging from intraday to one week out. Track how the market has reacted to past earnings to identify patterns and predict future behavior. Click here to open.

CAMP

CAMP4 Therapeutics Corp

Dec 12 • 04:00PM ET

8.88

Dollar change +0.40
Percentage change 4.72	%

Healthcare • Biotechnology • USA • NASD

Held by: VTI VXF VTWO VTWG VTWV

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-	Insider Own	80.57%	Shs Outstand	20.16M	Perf Week	-9.48%
Market Cap	179.03M	Forward P/E	-	EPS next Y	-	Insider Trans	66.55%	Shs Float	3.79M	Perf Month	-24.36%
Income	-	PEG	-	EPS next Q	-0.82	Inst Own	-	Short Float	10.70%	Perf Quarter	-
Sales	-	P/S	-	EPS this Y	-	Inst Trans	-	Short Ratio	3.67	Perf Half Y	-
Book/sh	-7.89	P/B	-	EPS next Y	-	ROA	-	Short Interest	0.41M	Perf Year	-
Cash/sh	0.13	P/C	70.76	EPS next 5Y	-	ROE	-	52W Range	4.06 - 12.30	Perf YTD	-17.16%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-27.80%	Beta	-
Dividend TTM	-	Quick Ratio	0.47	Sales past 5Y	0.00%	Gross Margin	-	52W Low	118.71%	ATR (14)	1.60
Dividend Ex-Date	-	Current Ratio	0.47	EPS Y/Y TTM	-	Oper. Margin	-	RSI (14)	54.94	Volatility	21.50% 24.73%
Employees	58	Debt/Eq	3.04	Sales Y/Y TTM	-	Profit Margin	-	Recom	1.00	Target Price	21.11
Option/Short	No / Yes	LT Debt/Eq	2.01	EPS Q/Q	-	Payout	-	Rel Volume	0.94	Prev Close	8.48
Sales Surprise	-100.00%	EPS Surprise	-2153.59%	Sales Q/Q	-	Earnings	Nov 21 AMC	Avg Volume	110.58K	Price	8.88
SMA20	31.85%	SMA50	0.75%	SMA200	0.75%	Trades		Volume	103,931	Change	4.72%

Date	Action	Analyst	Rating Change	Price Target Change
Nov-05-24	Initiated	William Blair	Outperform
Nov-05-24	Initiated	Piper Sandler	Overweight	$18
Nov-05-24	Initiated	JP Morgan	Overweight	$23

Dec-10-24 08:00AM	CAMP4 Appoints John Maraganore and Rachel Meyers as Strategic Advisors (GlobeNewswire) -8.08%
Dec-02-24 08:00AM	CAMP4 to Participate in the Piper Sandler 36th Annual Healthcare Conference (GlobeNewswire) +5.85%
Nov-21-24 04:05PM	CAMP4 Reports Third Quarter 2024 Financial Results (GlobeNewswire) +8.44% -6.40%
Oct-10-24 07:07PM	CAMP4 Announces Pricing of Initial Public Offering (GlobeNewswire)

CAMP4 Therapeutics Corp. operates as a biotechnology company which engages in the discovery of treatment options for patients. The company was founded by Richard A. Young and Leonard Zon in 2015 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Northpond Ventures II GP, LLC	10% Owner	Oct 15 '24	Buy	11.00	763,636	8,399,996	763,636	Oct 17 06:34 PM
AH Equity Partners Bio I, L.L.	10% Owner	Oct 15 '24	Buy	11.00	727,272	7,999,992	1,579,885	Oct 17 05:05 PM
Enavate Sciences GP, LLC	10% Owner	Oct 15 '24	Buy	11.00	1,363,636	14,999,996	3,785,802	Oct 17 04:15 PM
Polaris Management Co. VII, L.	10% Owner	Oct 15 '24	Buy	11.00	909,090	9,999,990	909,090	Oct 15 06:00 PM
5AM Partners VI, LLC	10% Owner	Oct 15 '24	Buy	11.00	909,090	9,999,990	2,625,145	Oct 15 05:56 PM
Nashat Amir	Director	Oct 15 '24	Buy	11.00	909,090	9,999,990	909,090	Oct 15 05:49 PM
Schwab Andrew J.	Director	Oct 15 '24	Buy	11.00	909,090	9,999,990	2,625,145	Oct 15 05:48 PM
Cohenour Jason	Director	Jun 05 '24	Sale	0.83	8,640	7,176	0	Jun 06 09:00 AM
Cohenour Jason	Director	Mar 05 '24	Option Exercise	0.00	7,824	0	10,962	Mar 07 07:41 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

CAMP

CAMP4 Therapeutics Corp

Upgrade your FINVIZ experience